News About: Pharm. Industry
Korea drug patents still at lower level on its quality.
The drug patents of Korea showed a remarkable progress in its registration volumes over the world but still remained on an infant phase in terms of its quality.
The Korea Patent Office report titled "2006 patent st...
Seroquel as top therapy for manic depressive psychosis.
AstraZeneca (AZ) Korea said on Aug. 13 that Seroquel (quetiapine fumarate) ranked the top product in the treatment of the manic depressive psychosis in Korea.
Seroquel was approved by the US FDA in 2006 for the in...
Abbott's new cancer agent has promising results in Phase 1 trial
Abbott Laboratories' cancer drug proved to be promising in its Phase I study after it showed signs of shrinking lung tumors, said a doctor who performed an earlier trial in Singapore.
The Phase II trial of the medi...
Novel blood sugar biosensors to bring medical revolution
"New biosensor technology for monitoring glucose levels in people with diabetes is moving ahead rapidly as a growing number of Korean biopharmaceutical companies are struggling to develop tailored systems of combining...
Dong-A to commit $68 mil. worth of export sales to Russia and east Europe.Dong-A made an export sales agreement for the prescription and bio drugs with 5 companies in Turkey, Russia and Ukraine at the total U$68 mil. for 5 years to come. The total 7 p...
|
LG Life Science to distribute Sancuso exclusively.
LG Life Science announced on Aug. 10 that the company made a technical licence agreement with ProStrakan Group, a UK pharmaceutical company for an exclusive distribution of Sancuso, a patch form of anti-vomiting drug,...
VGX International to acquire pharmaceutical unit of JEC
VGX International announced on August 10 that it plans to take over the pharmaceutical unit of JEC, a local GMP consulting firm that provides total solutions for the biopharmaceutical manufacturing process facilities....
Ever growing Plavix and Lipitor sales encountered challenges.
Plavix, an anti-arteriosclerosis by Sanofi-Aventis and Lipitor, an anti-cholesterol drug by BMS Korea and Pfizer Korea, have enjoyed with ever growing sales in the market since long time but recently encountered with ...
Korean drug makers get a win in generic Lipitor case
Recently, a local Patent Trial Board ruled that a key patent that Pfizer holds on atorvastatin, the active ingredient in Lipitor, is invalid. The decision means that Pfizer's Korean patent on the drug, the world's top...
Small- and medium-sized pharmaceutical firms seek to expand facility investment
A growing number of facility construction projects have been promoted by several small- and medium-sized pharmaceutical firms to meet local demand.
Shinpoong Pharm said it will construct a new factory for the local...
